| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Catatonia | 33 | 2024 | 181 | 7.170 |
Why?
|
| Psychiatry | 15 | 2022 | 1715 | 1.790 |
Why?
|
| Mind-Body Therapies | 13 | 2022 | 294 | 1.690 |
Why?
|
| Neuropsychiatry | 3 | 2019 | 76 | 1.340 |
Why?
|
| Electroconvulsive Therapy | 8 | 2024 | 505 | 1.290 |
Why?
|
| Neurology | 4 | 2022 | 785 | 1.230 |
Why?
|
| Lorazepam | 9 | 2024 | 155 | 1.120 |
Why?
|
| Psychosomatic Medicine | 4 | 2014 | 72 | 1.100 |
Why?
|
| Fibromyalgia | 2 | 2023 | 407 | 1.060 |
Why?
|
| Anti-Anxiety Agents | 7 | 2012 | 404 | 1.050 |
Why?
|
| Meditation | 7 | 2022 | 256 | 1.040 |
Why?
|
| Stress, Psychological | 23 | 2024 | 4527 | 0.970 |
Why?
|
| Neuroleptic Malignant Syndrome | 3 | 2023 | 74 | 0.960 |
Why?
|
| Morphine | 13 | 2008 | 658 | 0.940 |
Why?
|
| Delusions | 3 | 2022 | 300 | 0.890 |
Why?
|
| Relaxation | 7 | 2018 | 51 | 0.880 |
Why?
|
| Burnout, Professional | 4 | 2021 | 710 | 0.870 |
Why?
|
| Delirium | 12 | 2024 | 1698 | 0.820 |
Why?
|
| Anxiety Disorders | 8 | 2012 | 2744 | 0.760 |
Why?
|
| Prisoners | 2 | 2021 | 315 | 0.710 |
Why?
|
| Mental Disorders | 14 | 2022 | 6869 | 0.710 |
Why?
|
| Antipsychotic Agents | 10 | 2024 | 3078 | 0.680 |
Why?
|
| Health Personnel | 4 | 2021 | 3384 | 0.660 |
Why?
|
| Depressive Disorder, Major | 8 | 2017 | 4810 | 0.650 |
Why?
|
| Psychophysiologic Disorders | 4 | 2014 | 222 | 0.640 |
Why?
|
| Refugees | 2 | 2017 | 615 | 0.630 |
Why?
|
| Depression | 22 | 2022 | 8228 | 0.580 |
Why?
|
| Fatigue | 3 | 2021 | 1555 | 0.560 |
Why?
|
| Adaptation, Psychological | 12 | 2021 | 2662 | 0.550 |
Why?
|
| Auditory Pathways | 1 | 2019 | 241 | 0.540 |
Why?
|
| Resilience, Psychological | 6 | 2022 | 808 | 0.540 |
Why?
|
| Hospitals, General | 5 | 2021 | 804 | 0.530 |
Why?
|
| Psychomotor Agitation | 4 | 2019 | 307 | 0.520 |
Why?
|
| Tinnitus | 1 | 2019 | 197 | 0.520 |
Why?
|
| Empathy | 3 | 2016 | 474 | 0.520 |
Why?
|
| Basal Ganglia | 2 | 2019 | 549 | 0.520 |
Why?
|
| Tai Ji | 3 | 2017 | 289 | 0.520 |
Why?
|
| Counterpulsation | 3 | 2002 | 16 | 0.520 |
Why?
|
| Correspondence as Topic | 1 | 2016 | 34 | 0.510 |
Why?
|
| Needs Assessment | 2 | 2017 | 1140 | 0.500 |
Why?
|
| Myocardial Infarction | 9 | 2010 | 11513 | 0.490 |
Why?
|
| Religion and Psychology | 2 | 2015 | 180 | 0.480 |
Why?
|
| Humans | 206 | 2024 | 766766 | 0.480 |
Why?
|
| Veterans | 4 | 2021 | 2667 | 0.470 |
Why?
|
| Grief | 2 | 2022 | 256 | 0.470 |
Why?
|
| Auditory Cortex | 1 | 2019 | 366 | 0.470 |
Why?
|
| Opioid Peptides | 7 | 2017 | 37 | 0.470 |
Why?
|
| Thalamus | 2 | 2019 | 1040 | 0.460 |
Why?
|
| Muscle Relaxants, Central | 1 | 2014 | 94 | 0.450 |
Why?
|
| Affective Symptoms | 5 | 2018 | 418 | 0.440 |
Why?
|
| Benzodiazepines | 7 | 2024 | 1137 | 0.430 |
Why?
|
| Neurosciences | 1 | 2018 | 384 | 0.430 |
Why?
|
| Relaxation Therapy | 5 | 2018 | 180 | 0.420 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 2 | 2022 | 903 | 0.420 |
Why?
|
| Family Practice | 1 | 2016 | 508 | 0.420 |
Why?
|
| Psychotic Disorders | 9 | 2024 | 3276 | 0.410 |
Why?
|
| Receptors, Opioid, mu | 6 | 2008 | 167 | 0.410 |
Why?
|
| Cognition | 6 | 2024 | 7057 | 0.400 |
Why?
|
| Diagnostic and Statistical Manual of Mental Disorders | 4 | 2017 | 1988 | 0.400 |
Why?
|
| Gyrus Cinguli | 1 | 2019 | 1118 | 0.400 |
Why?
|
| Granulocytes | 4 | 1998 | 551 | 0.400 |
Why?
|
| Limbic Encephalitis | 1 | 2012 | 36 | 0.400 |
Why?
|
| Hydrocephalus, Normal Pressure | 1 | 2013 | 101 | 0.390 |
Why?
|
| Adenovirus Infections, Human | 1 | 2012 | 76 | 0.390 |
Why?
|
| Program Development | 2 | 2020 | 1297 | 0.380 |
Why?
|
| Models, Psychological | 4 | 2024 | 823 | 0.380 |
Why?
|
| Mentors | 3 | 2015 | 671 | 0.380 |
Why?
|
| Arrhythmias, Cardiac | 6 | 2011 | 2258 | 0.370 |
Why?
|
| Personality Inventory | 5 | 2010 | 1019 | 0.370 |
Why?
|
| Nervous System Diseases | 6 | 2019 | 1659 | 0.360 |
Why?
|
| Clozapine | 3 | 2023 | 509 | 0.360 |
Why?
|
| Depressive Disorder | 8 | 2018 | 3715 | 0.360 |
Why?
|
| GABA Modulators | 2 | 2010 | 108 | 0.350 |
Why?
|
| Physician's Role | 2 | 2016 | 925 | 0.350 |
Why?
|
| Capacity Building | 2 | 2016 | 266 | 0.350 |
Why?
|
| Anxiety | 13 | 2022 | 4670 | 0.350 |
Why?
|
| Nitric Oxide | 11 | 2013 | 2141 | 0.340 |
Why?
|
| Encephalitis | 2 | 2015 | 441 | 0.320 |
Why?
|
| Stress, Physiological | 9 | 2013 | 1406 | 0.310 |
Why?
|
| Yoga | 3 | 2022 | 277 | 0.310 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2008 | 59 | 0.300 |
Why?
|
| Haloperidol | 3 | 2010 | 394 | 0.300 |
Why?
|
| Loneliness | 2 | 2021 | 211 | 0.300 |
Why?
|
| Hospitalization | 8 | 2024 | 10823 | 0.290 |
Why?
|
| Pilot Projects | 14 | 2021 | 8728 | 0.280 |
Why?
|
| Mental Health | 7 | 2022 | 3270 | 0.280 |
Why?
|
| Anticonvulsants | 1 | 2017 | 1921 | 0.280 |
Why?
|
| Syria | 2 | 2017 | 86 | 0.280 |
Why?
|
| Psychiatric Status Rating Scales | 5 | 2017 | 6020 | 0.270 |
Why?
|
| Female | 94 | 2024 | 396520 | 0.270 |
Why?
|
| Neuroimmunomodulation | 3 | 2008 | 186 | 0.270 |
Why?
|
| Nerve Net | 1 | 2019 | 2307 | 0.270 |
Why?
|
| Lebanon | 2 | 2017 | 246 | 0.270 |
Why?
|
| Male | 90 | 2024 | 364142 | 0.270 |
Why?
|
| Propofol | 1 | 2012 | 608 | 0.260 |
Why?
|
| Motivation | 3 | 2021 | 2020 | 0.260 |
Why?
|
| Object Attachment | 3 | 2018 | 327 | 0.260 |
Why?
|
| Conversion Disorder | 2 | 2020 | 201 | 0.260 |
Why?
|
| Mental Health Services | 2 | 2012 | 1728 | 0.260 |
Why?
|
| Psychiatric Department, Hospital | 1 | 2006 | 133 | 0.250 |
Why?
|
| Antidepressive Agents | 3 | 2011 | 2903 | 0.250 |
Why?
|
| Health Services Accessibility | 3 | 2022 | 5514 | 0.250 |
Why?
|
| Internship and Residency | 4 | 2021 | 5943 | 0.240 |
Why?
|
| Cooperative Behavior | 3 | 2016 | 1512 | 0.240 |
Why?
|
| Bradycardia | 1 | 2007 | 304 | 0.240 |
Why?
|
| Monocytes | 4 | 1998 | 2600 | 0.240 |
Why?
|
| Middle Aged | 55 | 2024 | 223257 | 0.230 |
Why?
|
| Diazepam | 4 | 2024 | 215 | 0.230 |
Why?
|
| Angina Pectoris | 2 | 2001 | 956 | 0.230 |
Why?
|
| Movement Disorders | 2 | 2018 | 461 | 0.230 |
Why?
|
| Interdisciplinary Communication | 1 | 2010 | 932 | 0.230 |
Why?
|
| Deception | 2 | 1995 | 99 | 0.230 |
Why?
|
| Hypnotics and Sedatives | 1 | 2012 | 1193 | 0.230 |
Why?
|
| Referral and Consultation | 6 | 2022 | 3618 | 0.220 |
Why?
|
| Hyperparathyroidism | 1 | 2005 | 338 | 0.220 |
Why?
|
| Severity of Illness Index | 12 | 2024 | 15908 | 0.220 |
Why?
|
| Adult | 65 | 2024 | 223307 | 0.220 |
Why?
|
| Placebo Effect | 2 | 2005 | 515 | 0.220 |
Why?
|
| International Cooperation | 2 | 2012 | 1434 | 0.220 |
Why?
|
| Immune System | 4 | 2017 | 800 | 0.210 |
Why?
|
| Coma | 1 | 2007 | 485 | 0.210 |
Why?
|
| Enkephalins | 3 | 2005 | 139 | 0.210 |
Why?
|
| Receptors, Opioid | 3 | 2017 | 145 | 0.210 |
Why?
|
| Mass Screening | 5 | 2020 | 5454 | 0.200 |
Why?
|
| Patient-Centered Care | 1 | 2013 | 1445 | 0.200 |
Why?
|
| Hypercalcemia | 1 | 2005 | 425 | 0.200 |
Why?
|
| Hallucinations | 2 | 2022 | 373 | 0.200 |
Why?
|
| Brain Diseases | 2 | 2022 | 1552 | 0.200 |
Why?
|
| Sick Role | 4 | 1995 | 229 | 0.200 |
Why?
|
| Social Support | 5 | 2019 | 2191 | 0.200 |
Why?
|
| Invertebrates | 2 | 2002 | 55 | 0.200 |
Why?
|
| History, 20th Century | 4 | 2016 | 2764 | 0.200 |
Why?
|
| Developing Countries | 3 | 2018 | 2913 | 0.200 |
Why?
|
| Acquired Immunodeficiency Syndrome | 3 | 2017 | 2205 | 0.200 |
Why?
|
| Humanism | 2 | 1993 | 84 | 0.200 |
Why?
|
| Quinolones | 1 | 2005 | 389 | 0.200 |
Why?
|
| Electroencephalography | 8 | 2024 | 6282 | 0.190 |
Why?
|
| Fear | 2 | 2023 | 1496 | 0.190 |
Why?
|
| Akinetic Mutism | 1 | 2021 | 11 | 0.190 |
Why?
|
| Dopamine | 4 | 2005 | 1581 | 0.190 |
Why?
|
| Narcotics | 3 | 2005 | 332 | 0.190 |
Why?
|
| Social Adjustment | 3 | 2003 | 634 | 0.190 |
Why?
|
| Dyskinesias | 1 | 2022 | 79 | 0.190 |
Why?
|
| Psychopharmacology | 1 | 2023 | 146 | 0.190 |
Why?
|
| Music Therapy | 3 | 2013 | 111 | 0.190 |
Why?
|
| Hostility | 2 | 1999 | 185 | 0.180 |
Why?
|
| Syndrome | 4 | 2023 | 3271 | 0.180 |
Why?
|
| Nervous System Physiological Phenomena | 3 | 2001 | 113 | 0.180 |
Why?
|
| Middle East | 2 | 2019 | 234 | 0.180 |
Why?
|
| Interpersonal Relations | 2 | 2019 | 1432 | 0.180 |
Why?
|
| Research Personnel | 2 | 2016 | 589 | 0.180 |
Why?
|
| Pandemics | 7 | 2021 | 8735 | 0.180 |
Why?
|
| Psychological Techniques | 1 | 2020 | 48 | 0.170 |
Why?
|
| Aged | 35 | 2024 | 171343 | 0.170 |
Why?
|
| Blood Cell Count | 2 | 2013 | 405 | 0.170 |
Why?
|
| Ileus | 1 | 2020 | 65 | 0.170 |
Why?
|
| Limbic System | 3 | 2017 | 418 | 0.170 |
Why?
|
| Diagnosis, Differential | 9 | 2012 | 12985 | 0.170 |
Why?
|
| Military Personnel | 2 | 2019 | 1260 | 0.160 |
Why?
|
| Somatoform Disorders | 2 | 2018 | 425 | 0.160 |
Why?
|
| Ethiopia | 2 | 2012 | 485 | 0.160 |
Why?
|
| Telemedicine | 3 | 2022 | 3111 | 0.160 |
Why?
|
| Personnel, Hospital | 1 | 2020 | 285 | 0.150 |
Why?
|
| Coronavirus Infections | 3 | 2020 | 3110 | 0.150 |
Why?
|
| Pneumonia, Viral | 3 | 2020 | 3232 | 0.150 |
Why?
|
| Inpatients | 6 | 2024 | 2565 | 0.150 |
Why?
|
| Brain | 11 | 2024 | 27159 | 0.150 |
Why?
|
| Endophenotypes | 1 | 2020 | 258 | 0.150 |
Why?
|
| Sensation Disorders | 1 | 2019 | 160 | 0.150 |
Why?
|
| Social Isolation | 2 | 2012 | 366 | 0.150 |
Why?
|
| Students | 2 | 2020 | 1741 | 0.140 |
Why?
|
| Histiocytic Sarcoma | 1 | 1997 | 40 | 0.140 |
Why?
|
| Disease | 2 | 1993 | 675 | 0.140 |
Why?
|
| Vertebrates | 1 | 1998 | 227 | 0.140 |
Why?
|
| Primary Health Care | 3 | 2010 | 4735 | 0.140 |
Why?
|
| Labor, Induced | 1 | 2018 | 153 | 0.140 |
Why?
|
| Attitude to Health | 4 | 2002 | 2021 | 0.130 |
Why?
|
| Psychophysiology | 3 | 2001 | 136 | 0.130 |
Why?
|
| Health Resources | 3 | 2020 | 951 | 0.130 |
Why?
|
| Individuality | 1 | 2018 | 303 | 0.130 |
Why?
|
| Academic Medical Centers | 2 | 2011 | 2783 | 0.130 |
Why?
|
| Vitamin D Deficiency | 1 | 2005 | 1349 | 0.130 |
Why?
|
| Dissociative Disorders | 1 | 2018 | 234 | 0.130 |
Why?
|
| Altruism | 1 | 2017 | 211 | 0.130 |
Why?
|
| Health Status | 4 | 2017 | 4087 | 0.120 |
Why?
|
| Job Satisfaction | 1 | 2019 | 548 | 0.120 |
Why?
|
| History, 21st Century | 2 | 2015 | 1574 | 0.120 |
Why?
|
| Neurosecretory Systems | 1 | 2017 | 223 | 0.120 |
Why?
|
| Chronic Disease | 4 | 2020 | 9357 | 0.120 |
Why?
|
| Health Education | 1 | 2002 | 1060 | 0.120 |
Why?
|
| Piperazines | 1 | 2005 | 2547 | 0.120 |
Why?
|
| Neutropenia | 1 | 2020 | 894 | 0.120 |
Why?
|
| Language Disorders | 2 | 1986 | 140 | 0.120 |
Why?
|
| Adult Survivors of Child Abuse | 1 | 2018 | 301 | 0.120 |
Why?
|
| Pain | 5 | 2019 | 5098 | 0.120 |
Why?
|
| Cathexis | 1 | 1994 | 3 | 0.120 |
Why?
|
| General Adaptation Syndrome | 1 | 1994 | 7 | 0.110 |
Why?
|
| Environment | 1 | 2020 | 1120 | 0.110 |
Why?
|
| Psychometrics | 5 | 2018 | 3060 | 0.110 |
Why?
|
| Personality | 1 | 2018 | 560 | 0.110 |
Why?
|
| Endothelium, Vascular | 4 | 2000 | 4424 | 0.110 |
Why?
|
| Psychology | 2 | 1993 | 353 | 0.110 |
Why?
|
| Forecasting | 3 | 2010 | 2936 | 0.110 |
Why?
|
| Treatment Outcome | 15 | 2024 | 65273 | 0.110 |
Why?
|
| Prospective Studies | 13 | 2024 | 54871 | 0.110 |
Why?
|
| Fellowships and Scholarships | 2 | 2015 | 1134 | 0.110 |
Why?
|
| Neuropsychological Tests | 6 | 2017 | 7119 | 0.110 |
Why?
|
| Seizures | 3 | 2022 | 2996 | 0.110 |
Why?
|
| Quality of Life | 6 | 2021 | 13476 | 0.110 |
Why?
|
| United States | 13 | 2024 | 72951 | 0.110 |
Why?
|
| Schizophrenia, Paranoid | 3 | 2009 | 102 | 0.110 |
Why?
|
| Amygdala | 2 | 2020 | 1375 | 0.110 |
Why?
|
| Workplace | 1 | 2019 | 873 | 0.100 |
Why?
|
| Microglia | 2 | 2019 | 1370 | 0.100 |
Why?
|
| Mind-Body Relations, Metaphysical | 2 | 2010 | 34 | 0.100 |
Why?
|
| Follow-Up Studies | 9 | 2018 | 39309 | 0.100 |
Why?
|
| Haiti | 1 | 2014 | 553 | 0.100 |
Why?
|
| Cytokines | 4 | 2023 | 7438 | 0.100 |
Why?
|
| Prevalence | 8 | 2019 | 15835 | 0.100 |
Why?
|
| Macrophages | 3 | 2001 | 5783 | 0.100 |
Why?
|
| Leukemia, Prolymphocytic, T-Cell | 1 | 2012 | 23 | 0.100 |
Why?
|
| Coronary Disease | 3 | 2000 | 5915 | 0.100 |
Why?
|
| Cost of Illness | 1 | 2022 | 1949 | 0.100 |
Why?
|
| Respiratory Tract Infections | 1 | 2020 | 1008 | 0.100 |
Why?
|
| Schizophrenia | 5 | 2020 | 6976 | 0.100 |
Why?
|
| Rwanda | 1 | 2014 | 673 | 0.100 |
Why?
|
| Allostasis | 1 | 2013 | 76 | 0.100 |
Why?
|
| Friends | 1 | 2013 | 150 | 0.100 |
Why?
|
| Fatal Outcome | 2 | 2012 | 1838 | 0.100 |
Why?
|
| Combined Modality Therapy | 3 | 2013 | 8540 | 0.100 |
Why?
|
| Herpesvirus 6, Human | 1 | 2012 | 96 | 0.100 |
Why?
|
| Professional-Family Relations | 1 | 2016 | 500 | 0.100 |
Why?
|
| Comorbidity | 3 | 2018 | 10580 | 0.100 |
Why?
|
| Substance-Related Disorders | 5 | 2017 | 4421 | 0.090 |
Why?
|
| International Educational Exchange | 1 | 2011 | 54 | 0.090 |
Why?
|
| Irritable Mood | 1 | 1993 | 196 | 0.090 |
Why?
|
| Psychotherapy | 1 | 2020 | 1648 | 0.090 |
Why?
|
| Socioeconomic Factors | 4 | 2020 | 7841 | 0.090 |
Why?
|
| Inflammation | 4 | 2023 | 10860 | 0.090 |
Why?
|
| Hypothalamo-Hypophyseal System | 3 | 2009 | 702 | 0.090 |
Why?
|
| Feasibility Studies | 4 | 2022 | 5306 | 0.090 |
Why?
|
| Physician-Patient Relations | 4 | 2003 | 3266 | 0.090 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 1994 | 362 | 0.090 |
Why?
|
| Decision Making | 2 | 2024 | 3951 | 0.090 |
Why?
|
| Biological Evolution | 5 | 2017 | 1075 | 0.090 |
Why?
|
| Pregnant Women | 1 | 2015 | 576 | 0.090 |
Why?
|
| Dopamine Agents | 1 | 2011 | 186 | 0.090 |
Why?
|
| Creatine Kinase | 1 | 2013 | 683 | 0.090 |
Why?
|
| Anti-Infective Agents | 1 | 1998 | 987 | 0.090 |
Why?
|
| Anxiety, Separation | 2 | 2005 | 85 | 0.090 |
Why?
|
| Emotions | 3 | 2021 | 2758 | 0.090 |
Why?
|
| Crime | 2 | 2020 | 206 | 0.090 |
Why?
|
| South Australia | 1 | 2010 | 27 | 0.090 |
Why?
|
| Heart Arrest | 2 | 1994 | 1516 | 0.090 |
Why?
|
| Megacolon, Toxic | 1 | 2009 | 8 | 0.090 |
Why?
|
| Professional Staff Committees | 1 | 2009 | 37 | 0.090 |
Why?
|
| Vasoconstriction | 1 | 1993 | 592 | 0.090 |
Why?
|
| Electronic Mail | 1 | 2011 | 215 | 0.080 |
Why?
|
| Energy Metabolism | 2 | 2013 | 2903 | 0.080 |
Why?
|
| Interviews as Topic | 1 | 2017 | 2741 | 0.080 |
Why?
|
| Patient Selection | 1 | 2022 | 4252 | 0.080 |
Why?
|
| Cardiac Surgical Procedures | 2 | 1996 | 3684 | 0.080 |
Why?
|
| Pituitary-Adrenal System | 2 | 2008 | 553 | 0.080 |
Why?
|
| Irritable Bowel Syndrome | 1 | 2015 | 454 | 0.080 |
Why?
|
| Japan | 1 | 2014 | 1417 | 0.080 |
Why?
|
| Self-Injurious Behavior | 1 | 2015 | 571 | 0.080 |
Why?
|
| Amantadine | 2 | 2024 | 58 | 0.080 |
Why?
|
| History, 19th Century | 2 | 2015 | 714 | 0.080 |
Why?
|
| Oxytocin | 2 | 2009 | 403 | 0.080 |
Why?
|
| Peptide Fragments | 2 | 2000 | 5143 | 0.080 |
Why?
|
| Videoconferencing | 1 | 2011 | 209 | 0.080 |
Why?
|
| Cyclophosphamide | 2 | 1997 | 2234 | 0.080 |
Why?
|
| Electric Countershock | 2 | 1989 | 534 | 0.080 |
Why?
|
| Postoperative Complications | 2 | 2008 | 15831 | 0.080 |
Why?
|
| Serotonin Antagonists | 1 | 2009 | 146 | 0.080 |
Why?
|
| Cesarean Section | 1 | 2018 | 1418 | 0.080 |
Why?
|
| Family | 4 | 2013 | 3209 | 0.080 |
Why?
|
| Reward | 2 | 2007 | 980 | 0.080 |
Why?
|
| Pregnancy Complications | 2 | 2018 | 2971 | 0.080 |
Why?
|
| Movement | 1 | 2015 | 1468 | 0.080 |
Why?
|
| Community Health Services | 1 | 2014 | 659 | 0.080 |
Why?
|
| Amitriptyline | 1 | 1989 | 110 | 0.080 |
Why?
|
| Puerperal Disorders | 2 | 2018 | 304 | 0.080 |
Why?
|
| Models, Biological | 4 | 2007 | 9461 | 0.080 |
Why?
|
| Tachycardia, Sinus | 1 | 2008 | 43 | 0.080 |
Why?
|
| Societies, Scientific | 1 | 2009 | 221 | 0.080 |
Why?
|
| Hippocampus | 3 | 2012 | 3776 | 0.080 |
Why?
|
| Tacrolimus | 1 | 2012 | 753 | 0.080 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 2008 | 205 | 0.080 |
Why?
|
| Coronary Care Units | 1 | 2010 | 235 | 0.080 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 1998 | 2270 | 0.070 |
Why?
|
| Serotonin | 1 | 1993 | 1045 | 0.070 |
Why?
|
| Kidney Failure, Chronic | 2 | 1992 | 2505 | 0.070 |
Why?
|
| Emigrants and Immigrants | 1 | 2014 | 550 | 0.070 |
Why?
|
| Motor Activity | 1 | 2018 | 2711 | 0.070 |
Why?
|
| Medically Underserved Area | 1 | 2010 | 268 | 0.070 |
Why?
|
| Gastrointestinal Motility | 1 | 2009 | 235 | 0.070 |
Why?
|
| Leukodystrophy, Metachromatic | 1 | 1988 | 44 | 0.070 |
Why?
|
| Life Change Events | 1 | 1993 | 956 | 0.070 |
Why?
|
| Burning Mouth Syndrome | 1 | 2007 | 25 | 0.070 |
Why?
|
| Remote Consultation | 1 | 2010 | 241 | 0.070 |
Why?
|
| Mental Status Schedule | 1 | 2008 | 315 | 0.070 |
Why?
|
| Self Care | 1 | 2013 | 800 | 0.070 |
Why?
|
| Down-Regulation | 4 | 2007 | 2931 | 0.070 |
Why?
|
| Academies and Institutes | 1 | 2009 | 326 | 0.070 |
Why?
|
| Randomized Controlled Trials as Topic | 3 | 2021 | 10384 | 0.070 |
Why?
|
| Lymphocytosis | 1 | 2008 | 121 | 0.070 |
Why?
|
| Signal Transduction | 6 | 2017 | 23619 | 0.070 |
Why?
|
| Alcohols | 1 | 2007 | 94 | 0.070 |
Why?
|
| Animals | 22 | 2018 | 168930 | 0.070 |
Why?
|
| Cytochrome P-450 CYP2D6 | 1 | 2007 | 108 | 0.070 |
Why?
|
| Panic Disorder | 2 | 2004 | 613 | 0.070 |
Why?
|
| Statistics, Nonparametric | 1 | 2012 | 2846 | 0.070 |
Why?
|
| Immunocompromised Host | 1 | 2012 | 865 | 0.070 |
Why?
|
| Neurotransmitter Agents | 3 | 1996 | 661 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 597 | 0.070 |
Why?
|
| Death, Sudden | 2 | 1986 | 301 | 0.070 |
Why?
|
| Behavior Therapy | 3 | 2001 | 886 | 0.070 |
Why?
|
| Autocrine Communication | 1 | 2007 | 168 | 0.070 |
Why?
|
| Professional Competence | 1 | 2009 | 429 | 0.070 |
Why?
|
| Diabetes Insipidus | 1 | 1987 | 144 | 0.070 |
Why?
|
| Aspirin | 1 | 1998 | 3135 | 0.070 |
Why?
|
| Qualitative Research | 1 | 2017 | 3138 | 0.070 |
Why?
|
| Adolescent | 10 | 2024 | 88904 | 0.070 |
Why?
|
| Compulsive Behavior | 1 | 1987 | 117 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 1999 | 3799 | 0.060 |
Why?
|
| Autistic Disorder | 2 | 2011 | 1238 | 0.060 |
Why?
|
| Caregivers | 1 | 2018 | 2303 | 0.060 |
Why?
|
| Internationality | 1 | 2011 | 1006 | 0.060 |
Why?
|
| Education, Medical | 3 | 2011 | 1744 | 0.060 |
Why?
|
| Drug Resistance | 2 | 2011 | 1592 | 0.060 |
Why?
|
| Dementia | 2 | 2008 | 2741 | 0.060 |
Why?
|
| Recurrence | 2 | 2008 | 8507 | 0.060 |
Why?
|
| Biomedical Research | 2 | 2015 | 3459 | 0.060 |
Why?
|
| Drinking | 1 | 1987 | 196 | 0.060 |
Why?
|
| Outpatients | 1 | 2014 | 1596 | 0.060 |
Why?
|
| Child Behavior | 1 | 2011 | 864 | 0.060 |
Why?
|
| Paracrine Communication | 1 | 2007 | 277 | 0.060 |
Why?
|
| Alcoholism | 2 | 2008 | 1980 | 0.060 |
Why?
|
| Suicidal Ideation | 1 | 2015 | 1467 | 0.060 |
Why?
|
| Peripheral Nervous System | 1 | 2006 | 151 | 0.060 |
Why?
|
| Bulimia | 1 | 1988 | 405 | 0.060 |
Why?
|
| Catechol O-Methyltransferase | 1 | 2007 | 250 | 0.060 |
Why?
|
| Cross-Sectional Studies | 5 | 2022 | 26310 | 0.060 |
Why?
|
| Electrocardiography | 2 | 2008 | 6408 | 0.060 |
Why?
|
| Defibrillators, Implantable | 1 | 1994 | 1499 | 0.060 |
Why?
|
| Brain Mapping | 3 | 2012 | 6596 | 0.060 |
Why?
|
| Gene Expression Regulation | 4 | 2017 | 11920 | 0.060 |
Why?
|
| Cerebrospinal Fluid | 1 | 2008 | 540 | 0.060 |
Why?
|
| Medicine in Literature | 1 | 1985 | 32 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2007 | 481 | 0.060 |
Why?
|
| Neurologic Examination | 1 | 2008 | 913 | 0.060 |
Why?
|
| Huntington Disease | 1 | 2011 | 1147 | 0.060 |
Why?
|
| Ambulatory Care Facilities | 2 | 2001 | 939 | 0.060 |
Why?
|
| Suicide | 1 | 2015 | 1606 | 0.060 |
Why?
|
| Basal Ganglia Diseases | 1 | 1985 | 145 | 0.060 |
Why?
|
| Role | 1 | 1985 | 176 | 0.060 |
Why?
|
| Culture | 2 | 2005 | 622 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 1 | 2012 | 2730 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2009 | 1419 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2002 | 2160 | 0.060 |
Why?
|
| Frontal Lobe | 2 | 2008 | 1408 | 0.050 |
Why?
|
| Massachusetts | 3 | 2015 | 8891 | 0.050 |
Why?
|
| Memantine | 1 | 2024 | 110 | 0.050 |
Why?
|
| Cerebral Cortex | 3 | 2017 | 5753 | 0.050 |
Why?
|
| Substance Withdrawal Syndrome | 1 | 2008 | 627 | 0.050 |
Why?
|
| Risk Factors | 7 | 2024 | 74881 | 0.050 |
Why?
|
| Curriculum | 2 | 2014 | 3783 | 0.050 |
Why?
|
| Attention | 2 | 2006 | 2413 | 0.050 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1989 | 713 | 0.050 |
Why?
|
| Juvenile Delinquency | 1 | 2003 | 115 | 0.050 |
Why?
|
| Young Adult | 9 | 2024 | 59939 | 0.050 |
Why?
|
| Schizophrenic Psychology | 2 | 1987 | 1647 | 0.050 |
Why?
|
| Analgesics, Opioid | 2 | 2003 | 3837 | 0.050 |
Why?
|
| Narcissism | 1 | 1983 | 59 | 0.050 |
Why?
|
| Internet | 2 | 2012 | 3113 | 0.050 |
Why?
|
| Bipolar Disorder | 3 | 2020 | 5130 | 0.050 |
Why?
|
| Dracunculus Nematode | 1 | 2002 | 9 | 0.050 |
Why?
|
| Psychotropic Drugs | 1 | 2008 | 880 | 0.050 |
Why?
|
| Risk Assessment | 4 | 2020 | 24295 | 0.050 |
Why?
|
| Blood Pressure | 1 | 2018 | 8533 | 0.050 |
Why?
|
| Nicotine | 1 | 2007 | 680 | 0.050 |
Why?
|
| Stress Disorders, Post-Traumatic | 1 | 2020 | 4628 | 0.050 |
Why?
|
| Patient Acceptance of Health Care | 2 | 2014 | 3230 | 0.050 |
Why?
|
| Mood Disorders | 1 | 1989 | 1127 | 0.050 |
Why?
|
| Cocaine | 1 | 2007 | 944 | 0.050 |
Why?
|
| Ethanol | 1 | 2008 | 1326 | 0.050 |
Why?
|
| Overweight | 1 | 2013 | 2446 | 0.050 |
Why?
|
| Research Support as Topic | 1 | 2006 | 697 | 0.050 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2014 | 3408 | 0.050 |
Why?
|
| Pregnancy | 6 | 2018 | 30237 | 0.050 |
Why?
|
| Attitude to Death | 1 | 1985 | 400 | 0.050 |
Why?
|
| N-Methylaspartate | 1 | 2022 | 231 | 0.050 |
Why?
|
| Education, Medical, Graduate | 1 | 2014 | 2418 | 0.050 |
Why?
|
| Functional Laterality | 1 | 2008 | 2243 | 0.050 |
Why?
|
| Protein Precursors | 3 | 2005 | 1134 | 0.050 |
Why?
|
| Weight Loss | 1 | 2013 | 2712 | 0.050 |
Why?
|
| Chest Pain | 1 | 2008 | 1101 | 0.050 |
Why?
|
| Colon | 1 | 2009 | 1797 | 0.050 |
Why?
|
| Hydrocortisone | 4 | 2008 | 1838 | 0.050 |
Why?
|
| Behavior, Animal | 1 | 2009 | 1865 | 0.050 |
Why?
|
| Thoracic Surgical Procedures | 1 | 2005 | 348 | 0.050 |
Why?
|
| Age Distribution | 2 | 2018 | 2869 | 0.050 |
Why?
|
| Schistosoma mansoni | 1 | 2002 | 156 | 0.050 |
Why?
|
| Psychological Theory | 1 | 2002 | 172 | 0.050 |
Why?
|
| Enkephalin, Methionine | 2 | 2000 | 26 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 1983 | 447 | 0.040 |
Why?
|
| Leukopoiesis | 1 | 2020 | 54 | 0.040 |
Why?
|
| Terminally Ill | 2 | 1993 | 240 | 0.040 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2015 | 2429 | 0.040 |
Why?
|
| Valproic Acid | 1 | 2023 | 444 | 0.040 |
Why?
|
| Stroke | 1 | 2022 | 9741 | 0.040 |
Why?
|
| Child | 7 | 2024 | 80668 | 0.040 |
Why?
|
| Patient Satisfaction | 1 | 2012 | 3485 | 0.040 |
Why?
|
| Age Factors | 2 | 2024 | 18397 | 0.040 |
Why?
|
| Cohort Studies | 4 | 2024 | 41710 | 0.040 |
Why?
|
| Molecular Sequence Data | 3 | 2008 | 17608 | 0.040 |
Why?
|
| Sleep | 1 | 2015 | 4815 | 0.040 |
Why?
|
| Drug Tolerance | 2 | 2005 | 365 | 0.040 |
Why?
|
| Fatigue Syndrome, Chronic | 1 | 2001 | 217 | 0.040 |
Why?
|
| Cardiovascular Diseases | 4 | 2020 | 15657 | 0.040 |
Why?
|
| Anger | 2 | 1994 | 402 | 0.040 |
Why?
|
| Models, Neurological | 2 | 2005 | 1747 | 0.040 |
Why?
|
| Retrospective Studies | 7 | 2024 | 81635 | 0.040 |
Why?
|
| Marital Status | 1 | 2001 | 426 | 0.040 |
Why?
|
| Median Eminence | 1 | 1999 | 28 | 0.040 |
Why?
|
| Aged, 80 and over | 8 | 2022 | 59550 | 0.040 |
Why?
|
| Central Nervous System | 1 | 2006 | 1345 | 0.040 |
Why?
|
| Hypertension | 2 | 2018 | 8616 | 0.040 |
Why?
|
| Adrenocorticotropic Hormone | 2 | 2002 | 618 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 6066 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 2005 | 2746 | 0.040 |
Why?
|
| Insulin | 1 | 2013 | 6608 | 0.040 |
Why?
|
| Patient Dropouts | 1 | 2001 | 411 | 0.040 |
Why?
|
| Fetal Distress | 1 | 2018 | 39 | 0.040 |
Why?
|
| Immunomodulation | 1 | 2022 | 548 | 0.040 |
Why?
|
| Whole Body Imaging | 1 | 2020 | 283 | 0.040 |
Why?
|
| Plasma Exchange | 1 | 2019 | 160 | 0.040 |
Why?
|
| Self Concept | 2 | 1995 | 1040 | 0.040 |
Why?
|
| Acute Coronary Syndrome | 1 | 2011 | 2186 | 0.040 |
Why?
|
| Noise | 1 | 2020 | 296 | 0.040 |
Why?
|
| Wound Healing | 1 | 2009 | 2800 | 0.040 |
Why?
|
| Parent-Child Relations | 2 | 1993 | 772 | 0.040 |
Why?
|
| Trust | 1 | 2003 | 532 | 0.040 |
Why?
|
| Drug Therapy, Combination | 1 | 2008 | 6307 | 0.040 |
Why?
|
| Methylprednisolone | 1 | 2019 | 387 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 8 | 2024 | 36567 | 0.040 |
Why?
|
| Neurosecretion | 1 | 2017 | 10 | 0.040 |
Why?
|
| Diagnostic Errors | 1 | 1985 | 1276 | 0.040 |
Why?
|
| Fetal Macrosomia | 1 | 2018 | 138 | 0.040 |
Why?
|
| Macrophage Colony-Stimulating Factor | 1 | 1997 | 186 | 0.030 |
Why?
|
| Protozoan Infections | 1 | 2017 | 39 | 0.030 |
Why?
|
| Base Sequence | 1 | 2008 | 12415 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2015 | 5368 | 0.030 |
Why?
|
| Patient Care | 2 | 1993 | 629 | 0.030 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 1751 | 0.030 |
Why?
|
| Heart Diseases | 1 | 2010 | 2817 | 0.030 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2018 | 137 | 0.030 |
Why?
|
| Child, Preschool | 4 | 2024 | 42577 | 0.030 |
Why?
|
| Abruptio Placentae | 1 | 2018 | 116 | 0.030 |
Why?
|
| Brain Chemistry | 1 | 2000 | 951 | 0.030 |
Why?
|
| Evidence-Based Medicine | 1 | 2009 | 3692 | 0.030 |
Why?
|
| Africa South of the Sahara | 1 | 2019 | 751 | 0.030 |
Why?
|
| Morbidity | 1 | 2022 | 1754 | 0.030 |
Why?
|
| Psychoneuroimmunology | 1 | 1996 | 13 | 0.030 |
Why?
|
| Inflammation Mediators | 2 | 2017 | 1889 | 0.030 |
Why?
|
| Neurodegenerative Diseases | 2 | 2002 | 1089 | 0.030 |
Why?
|
| Arteriosclerosis | 2 | 2002 | 1055 | 0.030 |
Why?
|
| Vasculitis | 1 | 2020 | 528 | 0.030 |
Why?
|
| Prisons | 1 | 2018 | 178 | 0.030 |
Why?
|
| Critical Illness | 1 | 2008 | 2750 | 0.030 |
Why?
|
| Psychology, Clinical | 1 | 2015 | 43 | 0.030 |
Why?
|
| Memory Disorders | 1 | 2022 | 1193 | 0.030 |
Why?
|
| Vasomotor System | 1 | 1996 | 208 | 0.030 |
Why?
|
| Rest | 1 | 2000 | 940 | 0.030 |
Why?
|
| Human Rights | 1 | 2018 | 312 | 0.030 |
Why?
|
| Saphenous Vein | 1 | 1998 | 519 | 0.030 |
Why?
|
| Estradiol | 2 | 2000 | 1947 | 0.030 |
Why?
|
| Glucocorticoids | 2 | 2019 | 2158 | 0.030 |
Why?
|
| Universities | 1 | 2020 | 1004 | 0.030 |
Why?
|
| Training Support | 1 | 2015 | 109 | 0.030 |
Why?
|
| Stillbirth | 1 | 2018 | 381 | 0.030 |
Why?
|
| Chemotaxis | 1 | 1997 | 598 | 0.030 |
Why?
|
| Alkaloids | 1 | 1996 | 192 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10745 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2017 | 303 | 0.030 |
Why?
|
| Psychoses, Substance-Induced | 1 | 1995 | 98 | 0.030 |
Why?
|
| Ethics, Research | 1 | 2016 | 178 | 0.030 |
Why?
|
| Calcium Channel Blockers | 1 | 1997 | 687 | 0.030 |
Why?
|
| Postpartum Hemorrhage | 1 | 2018 | 275 | 0.030 |
Why?
|
| Rodentia | 1 | 1996 | 262 | 0.030 |
Why?
|
| Cell Size | 1 | 1996 | 625 | 0.030 |
Why?
|
| Breathing Exercises | 1 | 2014 | 59 | 0.030 |
Why?
|
| Kidney Transplantation | 1 | 1989 | 4278 | 0.030 |
Why?
|
| Headache | 1 | 2022 | 1260 | 0.030 |
Why?
|
| Aggression | 1 | 2019 | 748 | 0.030 |
Why?
|
| Endorphins | 1 | 1994 | 73 | 0.030 |
Why?
|
| Fetal Growth Retardation | 1 | 2018 | 591 | 0.030 |
Why?
|
| Prognosis | 2 | 2008 | 29948 | 0.030 |
Why?
|
| Heart Function Tests | 1 | 1994 | 316 | 0.030 |
Why?
|
| Tegmentum Mesencephali | 1 | 1994 | 59 | 0.030 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 1997 | 678 | 0.030 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 1997 | 614 | 0.030 |
Why?
|
| Status Epilepticus | 1 | 2019 | 459 | 0.030 |
Why?
|
| Genes, fos | 1 | 1994 | 176 | 0.030 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2024 | 2418 | 0.030 |
Why?
|
| Paraventricular Hypothalamic Nucleus | 1 | 1994 | 121 | 0.030 |
Why?
|
| Emergency Service, Hospital | 1 | 2013 | 7871 | 0.030 |
Why?
|
| History, Early Modern 1451-1600 | 1 | 1993 | 3 | 0.030 |
Why?
|
| History, Modern 1601- | 1 | 1993 | 16 | 0.030 |
Why?
|
| Dementia, Multi-Infarct | 1 | 1993 | 10 | 0.030 |
Why?
|
| Rats | 4 | 2012 | 23717 | 0.030 |
Why?
|
| Perception | 2 | 2001 | 1204 | 0.030 |
Why?
|
| Shyness | 1 | 1993 | 21 | 0.030 |
Why?
|
| Chemotaxis, Leukocyte | 1 | 1996 | 661 | 0.030 |
Why?
|
| Program Evaluation | 2 | 2012 | 2504 | 0.030 |
Why?
|
| Ventricular Fibrillation | 2 | 1986 | 538 | 0.030 |
Why?
|
| Congenital Abnormalities | 1 | 2018 | 703 | 0.030 |
Why?
|
| Neprilysin | 1 | 1996 | 487 | 0.030 |
Why?
|
| History, Medieval | 1 | 1993 | 62 | 0.030 |
Why?
|
| AIDS Dementia Complex | 1 | 1994 | 154 | 0.030 |
Why?
|
| MMPI | 1 | 1993 | 80 | 0.030 |
Why?
|
| Gonadotropin-Releasing Hormone | 1 | 1999 | 1142 | 0.030 |
Why?
|
| Cultural Competency | 1 | 2016 | 303 | 0.030 |
Why?
|
| Macrophage Activation | 1 | 1996 | 553 | 0.030 |
Why?
|
| Lymphocyte Subsets | 1 | 1994 | 313 | 0.030 |
Why?
|
| Lipoproteins, LDL | 1 | 1996 | 642 | 0.030 |
Why?
|
| History, Ancient | 1 | 1993 | 213 | 0.030 |
Why?
|
| Guilt | 1 | 1993 | 92 | 0.030 |
Why?
|
| Group Processes | 1 | 2014 | 225 | 0.030 |
Why?
|
| Chemokine CXCL12 | 1 | 2014 | 457 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2007 | 12791 | 0.020 |
Why?
|
| Carbidopa | 1 | 2011 | 30 | 0.020 |
Why?
|
| Dance Therapy | 1 | 2011 | 8 | 0.020 |
Why?
|
| Focus Groups | 1 | 2018 | 1459 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 3796 | 0.020 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 1993 | 134 | 0.020 |
Why?
|
| Receptors, Estrogen | 1 | 2000 | 2251 | 0.020 |
Why?
|
| Income | 1 | 2020 | 1875 | 0.020 |
Why?
|
| Locus Coeruleus | 1 | 1994 | 241 | 0.020 |
Why?
|
| Cell Adhesion | 1 | 1998 | 3093 | 0.020 |
Why?
|
| Coronary Artery Bypass | 1 | 2000 | 2188 | 0.020 |
Why?
|
| Social Environment | 2 | 2009 | 1012 | 0.020 |
Why?
|
| Avoidance Learning | 1 | 1993 | 248 | 0.020 |
Why?
|
| Species Specificity | 1 | 1995 | 2413 | 0.020 |
Why?
|
| Parkinson Disease | 1 | 2005 | 2884 | 0.020 |
Why?
|
| Doxorubicin | 1 | 1997 | 2229 | 0.020 |
Why?
|
| Levodopa | 1 | 2011 | 221 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 1994 | 520 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 1996 | 771 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14652 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1641 | 0.020 |
Why?
|
| Educational Status | 2 | 2013 | 2510 | 0.020 |
Why?
|
| Cell Membrane | 1 | 2000 | 3641 | 0.020 |
Why?
|
| Length of Stay | 1 | 2024 | 6490 | 0.020 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2009 | 5387 | 0.020 |
Why?
|
| Bromocriptine | 1 | 2010 | 93 | 0.020 |
Why?
|
| Drug Combinations | 2 | 2011 | 2085 | 0.020 |
Why?
|
| Homeostasis | 2 | 2008 | 3342 | 0.020 |
Why?
|
| Autoantibodies | 1 | 2019 | 2115 | 0.020 |
Why?
|
| Immunologic Deficiency Syndromes | 1 | 1994 | 548 | 0.020 |
Why?
|
| Religion | 1 | 2013 | 376 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2012 | 8106 | 0.020 |
Why?
|
| Affect | 1 | 2017 | 1494 | 0.020 |
Why?
|
| Positron-Emission Tomography | 2 | 2019 | 6550 | 0.020 |
Why?
|
| Time Factors | 5 | 2020 | 40149 | 0.020 |
Why?
|
| Anti-HIV Agents | 1 | 2005 | 4562 | 0.020 |
Why?
|
| Receptors, Cell Surface | 1 | 1999 | 2815 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2005 | 4858 | 0.020 |
Why?
|
| Electrolytes | 1 | 2010 | 279 | 0.020 |
Why?
|
| Case-Control Studies | 2 | 2018 | 22248 | 0.020 |
Why?
|
| Fluoxetine | 1 | 1993 | 732 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2022 | 3465 | 0.020 |
Why?
|
| Patient Care Team | 1 | 2000 | 2519 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2017 | 1358 | 0.020 |
Why?
|
| Hospitals | 1 | 2022 | 3888 | 0.020 |
Why?
|
| Image Processing, Computer-Assisted | 2 | 2018 | 8926 | 0.020 |
Why?
|
| Life Style | 3 | 2010 | 3926 | 0.020 |
Why?
|
| Recovery of Function | 1 | 2019 | 2976 | 0.020 |
Why?
|
| Cell Communication | 1 | 1996 | 1660 | 0.020 |
Why?
|
| Poverty | 1 | 2020 | 2714 | 0.020 |
Why?
|
| Personal Satisfaction | 1 | 1993 | 642 | 0.020 |
Why?
|
| Mammals | 1 | 1994 | 1133 | 0.020 |
Why?
|
| China | 1 | 2014 | 2383 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2009 | 527 | 0.020 |
Why?
|
| Mortality | 1 | 2019 | 2910 | 0.020 |
Why?
|
| Immunity, Cellular | 1 | 1994 | 1560 | 0.020 |
Why?
|
| S-Nitroso-N-Acetylpenicillamine | 1 | 2007 | 23 | 0.020 |
Why?
|
| Dopamine Agonists | 1 | 2010 | 346 | 0.020 |
Why?
|
| Propensity Score | 1 | 2015 | 1972 | 0.020 |
Why?
|
| Information Dissemination | 1 | 2016 | 1142 | 0.020 |
Why?
|
| Disease Susceptibility | 1 | 2014 | 1791 | 0.020 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 1994 | 1139 | 0.020 |
Why?
|
| Water Intoxication | 1 | 1987 | 10 | 0.020 |
Why?
|
| Regression Analysis | 2 | 2011 | 6329 | 0.020 |
Why?
|
| Gene Expression | 1 | 2020 | 7585 | 0.020 |
Why?
|
| Single-Blind Method | 1 | 2011 | 1587 | 0.020 |
Why?
|
| Analgesics, Non-Narcotic | 1 | 2010 | 371 | 0.020 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 2002 | 4056 | 0.020 |
Why?
|
| NG-Nitroarginine Methyl Ester | 1 | 2007 | 262 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2017 | 2334 | 0.020 |
Why?
|
| Calcium | 1 | 2000 | 5783 | 0.020 |
Why?
|
| Suicide, Attempted | 1 | 2015 | 1413 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2012 | 2677 | 0.020 |
Why?
|
| Checklist | 1 | 2014 | 841 | 0.020 |
Why?
|
| Lung Neoplasms | 2 | 2009 | 13485 | 0.020 |
Why?
|
| Urban Population | 1 | 2015 | 2040 | 0.020 |
Why?
|
| Healthcare Disparities | 1 | 2022 | 3411 | 0.020 |
Why?
|
| Heart Failure | 1 | 2011 | 11882 | 0.020 |
Why?
|
| Death, Sudden, Cardiac | 1 | 1994 | 1567 | 0.020 |
Why?
|
| Tachycardia, Supraventricular | 1 | 1989 | 272 | 0.020 |
Why?
|
| Fluid Therapy | 1 | 2010 | 587 | 0.020 |
Why?
|
| Blood Coagulation Disorders | 1 | 2009 | 350 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 1995 | 2429 | 0.020 |
Why?
|
| Amnesia | 1 | 1988 | 257 | 0.020 |
Why?
|
| Schools | 1 | 2015 | 1495 | 0.020 |
Why?
|
| Premature Birth | 1 | 2018 | 1830 | 0.020 |
Why?
|
| Dantrolene | 1 | 1985 | 26 | 0.020 |
Why?
|
| Environmental Exposure | 1 | 2020 | 4554 | 0.020 |
Why?
|
| Disease Progression | 1 | 2022 | 13640 | 0.020 |
Why?
|
| Dominance, Cerebral | 1 | 1986 | 616 | 0.020 |
Why?
|
| Adjustment Disorders | 1 | 1985 | 68 | 0.020 |
Why?
|
| Medial Forebrain Bundle | 1 | 1985 | 42 | 0.020 |
Why?
|
| Pain Measurement | 1 | 1995 | 3576 | 0.020 |
Why?
|
| Cells, Cultured | 2 | 1997 | 18984 | 0.010 |
Why?
|
| Psychopathology | 1 | 1988 | 434 | 0.010 |
Why?
|
| Nitric Oxide Synthase | 2 | 1999 | 911 | 0.010 |
Why?
|
| Cardiovascular Agents | 1 | 2011 | 849 | 0.010 |
Why?
|
| Naloxone | 1 | 2007 | 372 | 0.010 |
Why?
|
| Trifluoperazine | 1 | 1983 | 40 | 0.010 |
Why?
|
| Neural Pathways | 1 | 1995 | 3079 | 0.010 |
Why?
|
| Guidelines as Topic | 1 | 2010 | 1394 | 0.010 |
Why?
|
| Boston | 2 | 2011 | 9346 | 0.010 |
Why?
|
| Hospital Mortality | 1 | 2018 | 5343 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 14762 | 0.010 |
Why?
|
| Neoplasms | 1 | 1993 | 22350 | 0.010 |
Why?
|
| Human Growth Hormone | 1 | 2008 | 640 | 0.010 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2012 | 2028 | 0.010 |
Why?
|
| Abdomen | 1 | 2009 | 1137 | 0.010 |
Why?
|
| Individuation | 1 | 1983 | 21 | 0.010 |
Why?
|
| Technology Assessment, Biomedical | 1 | 1986 | 312 | 0.010 |
Why?
|
| Faculty, Medical | 1 | 2011 | 1226 | 0.010 |
Why?
|
| Abdominal Pain | 1 | 2009 | 1069 | 0.010 |
Why?
|
| Shock, Septic | 1 | 2009 | 772 | 0.010 |
Why?
|
| Ego | 1 | 1983 | 94 | 0.010 |
Why?
|
| HIV Infections | 1 | 2009 | 17536 | 0.010 |
Why?
|
| Tachycardia | 1 | 1985 | 598 | 0.010 |
Why?
|
| Gene Expression Regulation, Enzymologic | 1 | 2007 | 1168 | 0.010 |
Why?
|
| Morphine Derivatives | 1 | 2002 | 43 | 0.010 |
Why?
|
| Narcotic Antagonists | 1 | 2007 | 591 | 0.010 |
Why?
|
| Personality Development | 1 | 1983 | 241 | 0.010 |
Why?
|
| Infant | 1 | 2024 | 36461 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 20144 | 0.010 |
Why?
|
| Public Health | 1 | 2015 | 2681 | 0.010 |
Why?
|
| Gene Expression Profiling | 1 | 2018 | 9525 | 0.010 |
Why?
|
| Coronary Vessels | 1 | 1993 | 3100 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1983 | 1377 | 0.010 |
Why?
|
| Physicians | 1 | 2019 | 4591 | 0.010 |
Why?
|
| Saliva | 1 | 2006 | 852 | 0.010 |
Why?
|
| Intelligence | 1 | 2006 | 925 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 1986 | 968 | 0.010 |
Why?
|
| Amino Acid Sequence | 2 | 2005 | 13411 | 0.010 |
Why?
|
| Micrococcus luteus | 1 | 2000 | 3 | 0.010 |
Why?
|
| Twins, Monozygotic | 1 | 1983 | 471 | 0.010 |
Why?
|
| Incidence | 1 | 1999 | 21525 | 0.010 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 1 | 2002 | 267 | 0.010 |
Why?
|
| Coronary Artery Disease | 2 | 2002 | 6558 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2011 | 2694 | 0.010 |
Why?
|
| Immune System Diseases | 1 | 2003 | 253 | 0.010 |
Why?
|
| Pregnancy Complications, Neoplastic | 1 | 2003 | 260 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2005 | 1824 | 0.010 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2007 | 4570 | 0.010 |
Why?
|
| Diagnostic Tests, Routine | 1 | 1986 | 789 | 0.010 |
Why?
|
| Psychomotor Performance | 1 | 2008 | 1885 | 0.010 |
Why?
|
| Mental Recall | 1 | 2006 | 1218 | 0.010 |
Why?
|
| Estrogen Antagonists | 1 | 2000 | 151 | 0.010 |
Why?
|
| Reaction Time | 1 | 2006 | 2085 | 0.010 |
Why?
|
| Hypothalamus | 1 | 1985 | 1003 | 0.010 |
Why?
|
| Mitochondria | 1 | 2013 | 3677 | 0.010 |
Why?
|
| Tissue Donors | 1 | 1989 | 2392 | 0.010 |
Why?
|
| Registries | 1 | 2015 | 8351 | 0.010 |
Why?
|
| Linear Models | 1 | 2009 | 5874 | 0.010 |
Why?
|
| Intracellular Membranes | 1 | 2000 | 386 | 0.010 |
Why?
|
| Leukocytes | 1 | 2007 | 2035 | 0.010 |
Why?
|
| Utilization Review | 1 | 2000 | 381 | 0.010 |
Why?
|
| Reference Values | 1 | 2006 | 4913 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2013 | 12430 | 0.010 |
Why?
|
| Acute Disease | 1 | 2009 | 7241 | 0.010 |
Why?
|
| Radiography | 1 | 2009 | 6968 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2014 | 10445 | 0.010 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2002 | 1528 | 0.010 |
Why?
|
| Serum Albumin, Bovine | 1 | 1999 | 319 | 0.010 |
Why?
|
| Mesencephalon | 1 | 2000 | 337 | 0.010 |
Why?
|
| Guanylate Cyclase | 1 | 1999 | 206 | 0.010 |
Why?
|
| Gram-Positive Bacterial Infections | 1 | 2000 | 340 | 0.010 |
Why?
|
| Cerebrovascular Disorders | 1 | 1985 | 1479 | 0.010 |
Why?
|
| Health Promotion | 1 | 2010 | 2209 | 0.010 |
Why?
|
| Exercise | 1 | 2014 | 5945 | 0.010 |
Why?
|
| Immunoblotting | 1 | 2000 | 1647 | 0.010 |
Why?
|
| Evolution, Molecular | 1 | 2005 | 1892 | 0.010 |
Why?
|
| Bivalvia | 1 | 1996 | 55 | 0.010 |
Why?
|
| Escherichia coli Infections | 1 | 2000 | 518 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2009 | 10100 | 0.010 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 1999 | 707 | 0.010 |
Why?
|
| Hospitals, Teaching | 1 | 2000 | 1156 | 0.010 |
Why?
|
| Tamoxifen | 1 | 2000 | 967 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 21162 | 0.010 |
Why?
|
| Aortic Aneurysm, Abdominal | 1 | 2005 | 1251 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1983 | 1962 | 0.010 |
Why?
|
| Arteries | 1 | 2000 | 1123 | 0.010 |
Why?
|
| Rats, Wistar | 1 | 1999 | 1889 | 0.010 |
Why?
|
| Age of Onset | 1 | 2002 | 3342 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2010 | 4855 | 0.010 |
Why?
|
| Arousal | 1 | 2000 | 1174 | 0.010 |
Why?
|
| Palliative Care | 1 | 1989 | 3640 | 0.010 |
Why?
|
| Respiration | 1 | 2000 | 1654 | 0.010 |
Why?
|
| Models, Immunological | 1 | 1996 | 517 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1999 | 3587 | 0.010 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 1993 | 54 | 0.010 |
Why?
|
| Risk | 1 | 1985 | 9602 | 0.010 |
Why?
|
| Heart Ventricles | 1 | 1985 | 3832 | 0.010 |
Why?
|
| Staphylococcus aureus | 1 | 2000 | 1429 | 0.010 |
Why?
|
| Anti-Bacterial Agents | 1 | 2010 | 7475 | 0.010 |
Why?
|
| Staphylococcal Infections | 1 | 2000 | 1396 | 0.010 |
Why?
|
| Obesity | 1 | 2013 | 13090 | 0.010 |
Why?
|
| Bone Neoplasms | 1 | 2003 | 2561 | 0.010 |
Why?
|
| Escherichia coli | 1 | 2000 | 4211 | 0.000 |
Why?
|
| Testosterone | 1 | 1999 | 2495 | 0.000 |
Why?
|
| Cost-Benefit Analysis | 1 | 2000 | 5536 | 0.000 |
Why?
|
| Mice | 1 | 2014 | 81889 | 0.000 |
Why?
|
| Sex Factors | 1 | 2001 | 10619 | 0.000 |
Why?
|
| Hospital Bed Capacity, 500 and over | 1 | 1986 | 113 | 0.000 |
Why?
|
| Enzyme Inhibitors | 1 | 1996 | 3721 | 0.000 |
Why?
|
| Electrodes, Implanted | 1 | 1989 | 835 | 0.000 |
Why?
|
| Predictive Value of Tests | 1 | 2001 | 15416 | 0.000 |
Why?
|
| New York | 1 | 1986 | 879 | 0.000 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2003 | 11872 | 0.000 |
Why?
|
| Biopsy | 1 | 1993 | 6779 | 0.000 |
Why?
|